Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Burden Associated With Pharmacotherapy Switching in Trigeminal Neuralgia

Burden Associated With Pharmacotherapy Switching in Trigeminal Neuralgia

By

An examination of treatment patterns among patients with trigeminal neuralgia suggests that this orofacial disorder appears to be significantly burdensome.

Erenumab Shows Promise in Treatment-Resistant Migraine

Erenumab Shows Promise in Treatment-Resistant Migraine

By

A recent study evaluated the safety and efficacy of erenumab in patients with episodic migraine who had experienced 2 to 4 previous preventive treatment failures, due to lack of efficacy or intolerable side effects.

FDA Concerned About Potential for Abuse, Addiction With Kratom

FDA Concerned About Potential for Abuse, Addiction With Kratom

By

An investigation of the 25 most prevalent compounds in kratom showed that these compounds share structural similarities with controlled opioid analgesics, such as morphine derivatives.

FDA Tentatively Approves Arymo ER Label Update for Abuse-Deterrent Claims

FDA Tentatively Approves Arymo ER Label Update for Abuse-Deterrent Claims

By

The FDA has tentatively approved an update to the Arymo ER extended-release tablets labeling to include data from an intranasal abuse-deterrent claim.

Topical Analgesics Aid Opioid Discontinuation, Pain Management

Topical Analgesics Aid Opioid Discontinuation, Pain Management

By

In a recent study, about half of the study patients taking opioids who were prescribed topical analgesics for pain management discontinued their opioids after 3 to 6 months of treatment.

More Articles by Da Hee Han, PharmD

Sign Up for Free e-Newsletters